Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026Business Wire · 2 days ago
Varex Imaging (NASDAQ:VREX) vs. Pulse Biosciences (NASDAQ:PLSE) Head to Head ReviewDefense World · 5 days ago
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid CenterGuruFocus · Oct 14, 2026
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid CenterBusiness Wire · Oct 14, 2026
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire · Oct 9, 2026
Pulse Biosciences' nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026Business Wire · Oct 8, 2026Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.31 | -$0.36 | Miss |
| May 4, 2026 | -$0.32 | -$0.27 | Beat |
| Feb 19, 2026 | -$0.27 | -$0.26 | Beat |
| Nov 5, 2025 | -$0.31 | -$0.29 | Beat |
| Aug 12, 2025 | -$0.26 | -$0.28 | Miss |
| May 8, 2025 | – | -$0.17 |